Arbor Pharmaceuticals Inc. FDA Inspection Record
Arbor Pharmaceuticals Inc. is an FDA-inspected facility (FEI 3006411608) located in Atlanta, GA, US. RegDataLab tracks 4 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Oct 15, 2021: No Action Indicated (NAI)
- Inspections on record
- 4 (1 VAI, 3 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 5, latest Sep 16, 2020
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 15, 2021 | No Action Indicated (NAI) | No citations listed |
| Jan 28, 2016 | No Action Indicated (NAI) | No citations listed |
| Aug 16, 2012 | No Action Indicated (NAI) | No citations listed |
| Aug 27, 2010 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Written program not followed (21 CFR 211.166(a)) Procedures to be written and followed (21 CFR 211.198(a)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Sep 16, 2020 | Class III | D-1625-2020 | Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes… Subpotent Drug |
| Sep 27, 2019 | Class III | D-0167-2020 | Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only… Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain… |
| Jul 21, 2016 | Class I | D-0105-2017 | Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20… Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning… |
| Apr 20, 2011 | Class III | D-705-2011 | Fluor-A-Day Chewable Tablets (Sodium Fluoride, USP & Xylitol), 1.0mg F, 236.79 mg Xylitol… Labeling; Label Error on Declared Strength; label incorrectly states that the tablets are quarter strength and (1.1mg sodium fluoride) but… |
| Oct 13, 2010 | Class II | D-093-2011 | Zinotic ES (Chloroxylenol 0.1%, Pramoxine HCl 1.0%, Zinc Acetate Dihydrate 1.0%, Otic… Impurities/Degradation Products: The affected batches, during stability testing, yielded results higher than acceptable levels of… |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0105-2017, this FEI as the recalling firm | Jul 21, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-093-2011, this FEI as the recalling firm | Oct 13, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 27, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Arbor Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Arbor Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Arbor Pharmaceuticals Inc.
- Location
- Atlanta, GA (US)
- Source
- inspections